September 19, 2012
None of these drugs can kill the HIV virus, but each class slows down the multiplication of the virus (replication) in a particular way.
Combination medications: Some manufacturers have combined more than one drug into a single tablet or capsule. Combinations within a single class are listed below. Combinations of more than one type of drug are discussed in Fact Sheet 470.
The first anti-HIV drugs. They block reverse transcription (the creation of viral DNA from RNA) by providing "decoy" building blocks that interrupt the process. Most are nucleoside analogs; tenofovir is a nucleotide analog.
| Year Approved* |
Generic Name | Trade Name | Also Known As: | Manufacturer |
| 1987 | Zidovudine | Retrovir | AZT, ZDV | ViiV Healthcare & generic |
| 1991 | Didanosine | Videx | ddI | Bristol-Myers Squibb & generic |
| 1992 | Zalcitabine | Hivid | ddC, dideoxycytidine |
Roche: Manufacture discontinued in 2006 |
| 1994 | Stavudine | Zerit | d4T | Bristol-Myers Squibb & generic |
| 1995 | Lamivudine | Epivir | 3TC | ViiV Healthcare & generic |
| 1997 | Zidovudine/ lamivudine | Combivir | Combines AZT and 3TC |
ViiV Healthcare & generic |
| 1998 | Abacavir | Ziagen | ABC | ViiV Healthcare & generic |
| 2000 | Zidovudine/ lamivudine/ abacavir | Trizivir | Combines AZT, 3TC, abacavir | ViiV Healthcare |
| 2001 | Tenofovir | Viread | TDF | Gilead Sciences & generic |
| 2003 | Emtricitabine | Emtriva | FTC | Gilead Sciences & generic |
| 2004 | Abacavir/lamivudine | Epzicom | Combines Ziagen and 3TC | ViiV Healthcare & generic |
| 2004 | Emtricitabine/tenofovir | Truvada | Combines Emtriva and Viread | Gilead Sciences & generic |
These also interrupt reverse transcription, by binding to the reverse transcriptase enzyme and restricting its activity.
| Year Approved* |
Generic Name | Trade Name | Also Known As: | Manufacturer |
| 1996 | Nevirapine | Viramune | NVP | Boehringer Ingelheim & generic |
| 1997 | Delavirdine | Rescriptor | DLV | ViiV Healthcare |
| 1998 | Efavirenz | Sustiva,Stocrin | EFV | Bristol-Myers Squibb & generic |
| 2008 | Etravirine | Intelence | ETR | Tibotec |
| 2011 | Rilpivirine | Edurant | Tibotec |
Block the action of protease, an enzyme that cuts HIV protein chains into specific proteins needed to assemble a new copy of the virus. NOTE: when you see "/r" after the name of a protease inhibitor, that means it is boosted with a small dose of ritonavir. For example, SQV/r means saquinavir boosted with ritonavir. At present, only lopinavir and ritonavir are available in a single pill.
| Year Approved* |
Generic Name | Trade Name | Also Known As: | Manufacturer |
| 1995 | Saquinavir | Invirase | SQV | Roche |
| 1996 | Ritonavir | Norvir | RTV | Abbott |
| 1996 | Indinavir | Crixivan | IDV | Merck |
| 1997 | Nelfinavir | Viracept | NFV | ViiV Healthcare |
| 1997 | Saquinavir | Fortovase; Manufacture discontinued in 2006 | Roche | |
| 1999 | Amprenavir | Agenerase; Manufacture discontinued in 2007 | ViiV Healthcare | |
| 2000 | Lopinavir/ritonavir | Kaletra, Aluvia | LPV | Abbott & generic |
| 2003 | Atazanavir | Reyataz®™ | ATV | Bristol-Myers Squibb |
| 2003 | Fosamprenavir | Lexiva®™, Telzir | FPV | ViiV Healthcare |
| 2005 | Tipranavir | Aptivus | TPV | Boehringer Ingelheim |
| 2006 | Darunavir | Prezista | DRV | Tibotec |
Block the action of integrase, an enzyme that inserts the viral DNA into the infected cell's DNA strands.
| Year Approved* |
Generic Name | Trade Name | Also Known As: | Manufacturer |
| 2007 | Raltegravir | Isentress | RGV | Merck |
| Elvitegravir | Gilead |
Prevent HIV from attaching to a cell.
| Year Approved* |
Generic Name | Trade Name | Also Known As: | Manufacturer |
| 2003 | Enfuvirtide | Fuzeon | T-20 | Trimeris/Roche |
| 2007 | Maraviroc | Selzentry, Celsentri | MVC | ViiV Healthcare |
These are a "mirror image" of part of the HIV genetic code that locks onto the virus to prevent it from functioning.
Use the body's chemical messengers to stimulate the immune response. Over a dozen immune modulators are being studied in humans.
*Year of approval in the U.S.A. Many generic versions have been approved under the President's Emergency Plan for AIDS Relief. See www.fda.gov/oia/pepfar.htm for more information.